From January 1, 2024 to March 31, 2024, the company has repurchased 4,000,000 shares, representing 2.22% for CNY 35.97 million. With this, the company has completed the repurchase of 4,000,000 shares, representing 2.22% for CNY 35.97 million under the buyback announced on October 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.14 CNY | -2.97% | +2.58% | -23.00% |
04-26 | Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023 | CI |
04-25 | Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-23.00% | 241M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
-2.71% | 159B |
- Stock Market
- Equities
- 002826 Stock
- News Tibet AIM Pharm. Inc.
- Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.